HEADER TRANSFERASE 03-JUN-16 5KBR TITLE PAK1 IN COMPLEX WITH 7-AZAINDOLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PAK 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ALPHA-PAK,P21-ACTIVATED KINASE 1,PAK-1,P65-PAK; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PAK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SERINE/THREONINE-PROTEIN KINASE PAK1, KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.FERGUSON REVDAT 3 27-SEP-23 5KBR 1 REMARK REVDAT 2 11-JAN-17 5KBR 1 JRNL REVDAT 1 28-SEP-16 5KBR 0 JRNL AUTH W.MCCOULL,E.J.HENNESSY,K.BLADES,C.CHUAQUI,J.E.DOWLING, JRNL AUTH 2 A.D.FERGUSON,F.W.GOLDBERG,N.HOWE,C.R.JONES,P.D.KEMMITT, JRNL AUTH 3 G.LAMONT,J.G.VARNES,R.A.WARD,B.YANG JRNL TITL OPTIMIZATION OF HIGHLY KINASE SELECTIVE BIS-ANILINO JRNL TITL 2 PYRIMIDINE PAK1 INHIBITORS. JRNL REF ACS MED CHEM LETT V. 7 1118 2016 JRNL REFN ISSN 1948-5875 JRNL PMID 27994749 JRNL DOI 10.1021/ACSMEDCHEMLETT.6B00322 REMARK 2 REMARK 2 RESOLUTION. 2.36 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.36 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 63.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 25789 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1309 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.36 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.46 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.17 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2856 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2350 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2714 REMARK 3 BIN R VALUE (WORKING SET) : 0.2320 REMARK 3 BIN FREE R VALUE : 0.2910 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.97 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 142 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4068 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 65.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 91.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.14290 REMARK 3 B22 (A**2) : -7.07110 REMARK 3 B33 (A**2) : 6.92820 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -5.98830 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.350 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.298 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.235 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.314 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.242 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4197 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5670 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1500 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 110 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 580 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4197 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 551 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4825 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.18 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.94 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.17 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -1.4305 -23.2230 13.8804 REMARK 3 T TENSOR REMARK 3 T11: -0.0790 T22: -0.4255 REMARK 3 T33: -0.3546 T12: -0.0367 REMARK 3 T13: 0.2503 T23: -0.0337 REMARK 3 L TENSOR REMARK 3 L11: 6.0105 L22: 3.5065 REMARK 3 L33: 9.5324 L12: 0.3885 REMARK 3 L13: -5.7208 L23: -1.6963 REMARK 3 S TENSOR REMARK 3 S11: -0.4160 S12: 0.3821 S13: -0.7545 REMARK 3 S21: 0.0604 S22: 0.0623 S23: 0.2632 REMARK 3 S31: 0.0062 S32: -0.9166 S33: 0.3537 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 31.5719 22.5341 14.3767 REMARK 3 T TENSOR REMARK 3 T11: 0.2317 T22: -0.2982 REMARK 3 T33: -0.1453 T12: 0.1098 REMARK 3 T13: 0.4166 T23: 0.0406 REMARK 3 L TENSOR REMARK 3 L11: 0.7114 L22: 1.8948 REMARK 3 L33: 1.7363 L12: 0.5980 REMARK 3 L13: -0.1520 L23: 0.4410 REMARK 3 S TENSOR REMARK 3 S11: -0.1193 S12: -0.2271 S13: -0.0143 REMARK 3 S21: 0.3376 S22: 0.0155 S23: 0.4677 REMARK 3 S31: 0.2473 S32: -0.0139 S33: 0.1038 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KBR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1000221999. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-MAY-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25829 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.360 REMARK 200 RESOLUTION RANGE LOW (A) : 81.830 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.36 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.85000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4P90 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULPHATE, 16% PEG 3350, REMARK 280 0.1M HEPES (PH 7.6), VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.91350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 254 REMARK 465 MET A 288 REMARK 465 ASP A 289 REMARK 465 VAL A 290 REMARK 465 ALA A 291 REMARK 465 THR A 292 REMARK 465 GLY A 293 REMARK 465 GLN A 294 REMARK 465 MET A 301 REMARK 465 ASN A 302 REMARK 465 LEU A 303 REMARK 465 GLN A 304 REMARK 465 GLN A 305 REMARK 465 GLN A 306 REMARK 465 PRO A 307 REMARK 465 LYS A 308 REMARK 465 LYS A 309 REMARK 465 LEU A 335 REMARK 465 VAL A 336 REMARK 465 GLY A 337 REMARK 465 ASP A 338 REMARK 465 GLU A 339 REMARK 465 LEU A 340 REMARK 465 GLN A 413 REMARK 465 ILE A 414 REMARK 465 THR A 415 REMARK 465 PRO A 416 REMARK 465 GLU A 417 REMARK 465 GLN A 418 REMARK 465 SER A 419 REMARK 465 LEU B 254 REMARK 465 GLN B 278 REMARK 465 GLY B 279 REMARK 465 ALA B 280 REMARK 465 SER B 281 REMARK 465 GLY B 282 REMARK 465 ASN B 302 REMARK 465 LEU B 303 REMARK 465 GLN B 304 REMARK 465 GLN B 305 REMARK 465 GLN B 306 REMARK 465 PRO B 307 REMARK 465 LYS B 308 REMARK 465 LYS B 309 REMARK 465 GLU B 310 REMARK 465 LEU B 311 REMARK 465 ILE B 312 REMARK 465 ILE B 313 REMARK 465 PHE B 408 REMARK 465 GLY B 409 REMARK 465 PHE B 410 REMARK 465 CYS B 411 REMARK 465 ALA B 412 REMARK 465 GLN B 413 REMARK 465 ILE B 414 REMARK 465 THR B 415 REMARK 465 PRO B 416 REMARK 465 GLU B 417 REMARK 465 GLN B 418 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 266 13.60 -68.04 REMARK 500 LYS A 275 96.39 -57.51 REMARK 500 ASN A 322 74.67 -115.36 REMARK 500 ARG A 388 -3.44 77.45 REMARK 500 ASP A 407 91.67 54.38 REMARK 500 ALA A 440 93.89 -67.72 REMARK 500 ARG B 388 -17.26 77.67 REMARK 500 TYR B 464 18.41 59.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 728 DISTANCE = 7.23 ANGSTROMS REMARK 525 HOH B 744 DISTANCE = 7.17 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IPW A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IPW B 601 DBREF 5KBR A 254 542 UNP Q13153 PAK1_HUMAN 254 542 DBREF 5KBR B 254 542 UNP Q13153 PAK1_HUMAN 254 542 SEQADV 5KBR ASN A 389 UNP Q13153 ASP 389 ENGINEERED MUTATION SEQADV 5KBR GLU A 423 UNP Q13153 THR 423 ENGINEERED MUTATION SEQADV 5KBR ASP A 503 UNP Q13153 GLU 503 ENGINEERED MUTATION SEQADV 5KBR ASN B 389 UNP Q13153 ASP 389 ENGINEERED MUTATION SEQADV 5KBR GLU B 423 UNP Q13153 THR 423 ENGINEERED MUTATION SEQADV 5KBR ASP B 503 UNP Q13153 GLU 503 ENGINEERED MUTATION SEQRES 1 A 289 LEU GLU LYS LEU ARG SER ILE VAL SER VAL GLY ASP PRO SEQRES 2 A 289 LYS LYS LYS TYR THR ARG PHE GLU LYS ILE GLY GLN GLY SEQRES 3 A 289 ALA SER GLY THR VAL TYR THR ALA MET ASP VAL ALA THR SEQRES 4 A 289 GLY GLN GLU VAL ALA ILE LYS GLN MET ASN LEU GLN GLN SEQRES 5 A 289 GLN PRO LYS LYS GLU LEU ILE ILE ASN GLU ILE LEU VAL SEQRES 6 A 289 MET ARG GLU ASN LYS ASN PRO ASN ILE VAL ASN TYR LEU SEQRES 7 A 289 ASP SER TYR LEU VAL GLY ASP GLU LEU TRP VAL VAL MET SEQRES 8 A 289 GLU TYR LEU ALA GLY GLY SER LEU THR ASP VAL VAL THR SEQRES 9 A 289 GLU THR CYS MET ASP GLU GLY GLN ILE ALA ALA VAL CYS SEQRES 10 A 289 ARG GLU CYS LEU GLN ALA LEU GLU PHE LEU HIS SER ASN SEQRES 11 A 289 GLN VAL ILE HIS ARG ASN ILE LYS SER ASP ASN ILE LEU SEQRES 12 A 289 LEU GLY MET ASP GLY SER VAL LYS LEU THR ASP PHE GLY SEQRES 13 A 289 PHE CYS ALA GLN ILE THR PRO GLU GLN SER LYS ARG SER SEQRES 14 A 289 GLU MET VAL GLY THR PRO TYR TRP MET ALA PRO GLU VAL SEQRES 15 A 289 VAL THR ARG LYS ALA TYR GLY PRO LYS VAL ASP ILE TRP SEQRES 16 A 289 SER LEU GLY ILE MET ALA ILE GLU MET ILE GLU GLY GLU SEQRES 17 A 289 PRO PRO TYR LEU ASN GLU ASN PRO LEU ARG ALA LEU TYR SEQRES 18 A 289 LEU ILE ALA THR ASN GLY THR PRO GLU LEU GLN ASN PRO SEQRES 19 A 289 GLU LYS LEU SER ALA ILE PHE ARG ASP PHE LEU ASN ARG SEQRES 20 A 289 CYS LEU ASP MET ASP VAL GLU LYS ARG GLY SER ALA LYS SEQRES 21 A 289 GLU LEU LEU GLN HIS GLN PHE LEU LYS ILE ALA LYS PRO SEQRES 22 A 289 LEU SER SER LEU THR PRO LEU ILE ALA ALA ALA LYS GLU SEQRES 23 A 289 ALA THR LYS SEQRES 1 B 289 LEU GLU LYS LEU ARG SER ILE VAL SER VAL GLY ASP PRO SEQRES 2 B 289 LYS LYS LYS TYR THR ARG PHE GLU LYS ILE GLY GLN GLY SEQRES 3 B 289 ALA SER GLY THR VAL TYR THR ALA MET ASP VAL ALA THR SEQRES 4 B 289 GLY GLN GLU VAL ALA ILE LYS GLN MET ASN LEU GLN GLN SEQRES 5 B 289 GLN PRO LYS LYS GLU LEU ILE ILE ASN GLU ILE LEU VAL SEQRES 6 B 289 MET ARG GLU ASN LYS ASN PRO ASN ILE VAL ASN TYR LEU SEQRES 7 B 289 ASP SER TYR LEU VAL GLY ASP GLU LEU TRP VAL VAL MET SEQRES 8 B 289 GLU TYR LEU ALA GLY GLY SER LEU THR ASP VAL VAL THR SEQRES 9 B 289 GLU THR CYS MET ASP GLU GLY GLN ILE ALA ALA VAL CYS SEQRES 10 B 289 ARG GLU CYS LEU GLN ALA LEU GLU PHE LEU HIS SER ASN SEQRES 11 B 289 GLN VAL ILE HIS ARG ASN ILE LYS SER ASP ASN ILE LEU SEQRES 12 B 289 LEU GLY MET ASP GLY SER VAL LYS LEU THR ASP PHE GLY SEQRES 13 B 289 PHE CYS ALA GLN ILE THR PRO GLU GLN SER LYS ARG SER SEQRES 14 B 289 GLU MET VAL GLY THR PRO TYR TRP MET ALA PRO GLU VAL SEQRES 15 B 289 VAL THR ARG LYS ALA TYR GLY PRO LYS VAL ASP ILE TRP SEQRES 16 B 289 SER LEU GLY ILE MET ALA ILE GLU MET ILE GLU GLY GLU SEQRES 17 B 289 PRO PRO TYR LEU ASN GLU ASN PRO LEU ARG ALA LEU TYR SEQRES 18 B 289 LEU ILE ALA THR ASN GLY THR PRO GLU LEU GLN ASN PRO SEQRES 19 B 289 GLU LYS LEU SER ALA ILE PHE ARG ASP PHE LEU ASN ARG SEQRES 20 B 289 CYS LEU ASP MET ASP VAL GLU LYS ARG GLY SER ALA LYS SEQRES 21 B 289 GLU LEU LEU GLN HIS GLN PHE LEU LYS ILE ALA LYS PRO SEQRES 22 B 289 LEU SER SER LEU THR PRO LEU ILE ALA ALA ALA LYS GLU SEQRES 23 B 289 ALA THR LYS HET IPW A 601 29 HET IPW B 601 29 HETNAM IPW (4-CHLOROPHENYL)-[5-(1-PIPERIDIN-4-YLPYRAZOL-4-YL)- HETNAM 2 IPW 1~{H}-PYRROLO[2,3-B]PYRIDIN-3-YL]METHANONE FORMUL 3 IPW 2(C22 H20 CL N5 O) FORMUL 5 HOH *72(H2 O) HELIX 1 AA1 LEU A 311 ASN A 322 1 12 HELIX 2 AA2 SER A 351 THR A 359 1 9 HELIX 3 AA3 ASP A 362 ASN A 383 1 22 HELIX 4 AA4 LYS A 391 ASP A 393 5 3 HELIX 5 AA5 THR A 427 MET A 431 5 5 HELIX 6 AA6 ALA A 432 THR A 437 1 6 HELIX 7 AA7 LYS A 444 GLY A 460 1 17 HELIX 8 AA8 ASN A 468 GLY A 480 1 13 HELIX 9 AA9 ASN A 486 LEU A 490 5 5 HELIX 10 AB1 SER A 491 LEU A 502 1 12 HELIX 11 AB2 SER A 511 GLN A 517 1 7 HELIX 12 AB3 HIS A 518 ALA A 524 5 7 HELIX 13 AB4 PRO A 526 SER A 529 5 4 HELIX 14 AB5 LEU A 530 LYS A 542 1 13 HELIX 15 AB6 LYS B 256 ILE B 260 5 5 HELIX 16 AB7 ASP B 265 LYS B 269 1 5 HELIX 17 AB8 GLU B 315 ASN B 322 1 8 HELIX 18 AB9 SER B 351 THR B 359 1 9 HELIX 19 AC1 ASP B 362 ASN B 383 1 22 HELIX 20 AC2 LYS B 391 ASP B 393 5 3 HELIX 21 AC3 ALA B 432 THR B 437 1 6 HELIX 22 AC4 LYS B 444 GLY B 460 1 17 HELIX 23 AC5 ASN B 468 ASN B 479 1 12 HELIX 24 AC6 ASN B 486 LEU B 490 5 5 HELIX 25 AC7 SER B 491 LEU B 502 1 12 HELIX 26 AC8 SER B 511 LEU B 516 1 6 HELIX 27 AC9 GLN B 517 ALA B 524 5 8 HELIX 28 AD1 PRO B 526 SER B 529 5 4 HELIX 29 AD2 LEU B 530 LYS B 542 1 13 SHEET 1 AA1 5 GLU A 274 GLN A 278 0 SHEET 2 AA1 5 THR A 283 THR A 286 -1 O VAL A 284 N GLY A 277 SHEET 3 AA1 5 VAL A 296 LYS A 299 -1 O ILE A 298 N TYR A 285 SHEET 4 AA1 5 VAL A 342 GLU A 345 -1 O MET A 344 N ALA A 297 SHEET 5 AA1 5 TYR A 330 ASP A 332 -1 N ASP A 332 O VAL A 343 SHEET 1 AA2 2 ILE A 395 LEU A 397 0 SHEET 2 AA2 2 VAL A 403 LEU A 405 -1 O LYS A 404 N LEU A 396 SHEET 1 AA3 5 TYR B 270 LYS B 275 0 SHEET 2 AA3 5 VAL B 284 ASP B 289 -1 O MET B 288 N THR B 271 SHEET 3 AA3 5 GLU B 295 GLN B 300 -1 O ILE B 298 N TYR B 285 SHEET 4 AA3 5 GLU B 339 GLU B 345 -1 O MET B 344 N ALA B 297 SHEET 5 AA3 5 TYR B 330 VAL B 336 -1 N LEU B 331 O VAL B 343 SHEET 1 AA4 2 ILE B 395 LEU B 397 0 SHEET 2 AA4 2 VAL B 403 LEU B 405 -1 O LYS B 404 N LEU B 396 SSBOND 1 CYS A 360 CYS B 360 1555 2645 2.83 SITE 1 AC1 13 ILE A 276 VAL A 284 ALA A 297 LYS A 299 SITE 2 AC1 13 GLU A 315 MET A 319 VAL A 328 MET A 344 SITE 3 AC1 13 GLU A 345 TYR A 346 LEU A 347 LEU A 396 SITE 4 AC1 13 THR A 406 SITE 1 AC2 11 VAL B 284 ALA B 297 LYS B 299 VAL B 342 SITE 2 AC2 11 MET B 344 GLU B 345 TYR B 346 LEU B 347 SITE 3 AC2 11 GLY B 350 ASP B 354 LEU B 396 CRYST1 61.818 81.827 65.914 90.00 107.05 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016177 0.000000 0.004961 0.00000 SCALE2 0.000000 0.012221 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015869 0.00000